We are live on ! Find out more
ACMC

AyurMaya Capital Management Company Portfolio holdings

AUM $148M
1-Year Est. Return 24.4%
This Fund
S&P 500
This Quarter Est. Return
-51.14%
1 Year Est. Return
+24.4%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$45.4M
AUM Growth
-$43M
Cap. Flow
-$1.83M
Cap. Flow %
-4.04%
Top 10 Hldgs %
100%
Holding
2
New
Increased
1
Reduced
Closed
1

Top Buys

Rank Stock Value
1
ALMS
Alumis Inc
ALMS
+$21.2M

Top Sells

Rank Stock Value
1
SLRN
ACELYRIN
SLRN
+$23.1M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALMS
1
Alumis Inc
ALMS
$3.54B
$45.4M 100%
15,139,707
+4,493,741
+42% +$21.2M
SLRN
2
DELISTED
ACELYRIN
SLRN
-9,334,735
Closed -$23.1M

Similar funds

AyurMaya Capital Management Company's Q2 2025 Portfolio in Review

As of Q2 2025, AyurMaya Capital Management Company held 2 positions worth $45.4M, down 49% from $88.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

AyurMaya Capital Management Company withdrew a net $1.83M in Q2 2025, closing 1 position. Its most notable exit was ACELYRIN, an estimated $23.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, AyurMaya Capital Management Company added an estimated $21.2M to Alumis Inc.

  • AyurMaya Capital Management Company added most to Alumis Inc in Q2 2025, an estimated $21.2M increase.
  • AyurMaya Capital Management Company fully exited ACELYRIN in Q2 2025, selling an estimated $23.1M.
  • AyurMaya Capital Management Company's ten largest holdings make up 100% of its $45.4M portfolio in Q2 2025.
  • AyurMaya Capital Management Company opened 0 new positions and closed 1 in Q2 2025.
  • AyurMaya Capital Management Company's portfolio value fell 49% quarter-over-quarter to $45.4M.

Based on AyurMaya Capital Management Company's 13F filing for Q2 2025, filed 14 Aug 2025.